Skip to content

Application observation on quality of life and cohabitation problems in patients with the suburethral PVDF band DynaMesh®-SIS (soft)

Application observation on quality of life and cohabitation problems in patients with the suburethral PVDF band DynaMesh®-SIS (soft) - Pro-AWB-SIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033888
Enrollment
100
Registered
2024-03-28
Start date
2020-08-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N39.3

Interventions

Group 1: Patients with stress incontinence caused by a hypermobile urethra and/or an intrinsic sphincter deficiency and who are treated with the surgical procedure (retropubic or transobturator) using

Sponsors

FEG Textiltechnik Forschungs- und Entwicklungsgesellschaft mbH
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - all patients who agree to data collection - all patients treated with the surgical procedure using the DynaMesh-SIS band - all patients who are legally competent and mentally capable of completing the questionnaires

Exclusion criteria

Exclusion criteria: -As this is an observation of routine clinical practice, no patients meeting the inclusion criteria will be excluded -Previously operated patients with a mesh product

Design outcomes

Primary

MeasureTime frame
The primary study aim is the subjective change in quality of life and cohabitation problems before and after the surgical treatment of stress urinary incontinence. For this purpose, the condition before the operation and 3, 12 and 36 months after the operation is recorded and compared using validated patient questionnaires (ICIQ-OAB, ICIQ-UI-SF) and a self-created questionnaire.

Secondary

MeasureTime frame
The secondary objectives include recording potential mesh-related complications with/without reoperation or other treatment-related issues. These data can assess the clinical and technical safety and performance of the relevant products after reclassification by the MDR (EU 2017/745) [Medical Devices Regulation] and can be systematically monitored further.

Countries

Germany

Contacts

Public ContactUlrich Füllers

Gynäkologische Tagesklinik GbR

info@gtk-krefeld.de+49 2151-80600

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026